about
B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic InterventionsRecent advances and novel treatment paradigms in acute lymphocytic leukemiaAntibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy.Targeted treatment for chronic lymphocytic leukemia.Phase I study of ofatumumab, a human anti-CD20 antibody, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphomaNew agents and approaches to the treatment of B-cell non-Hodgkin lymphoma.Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies.
P2860
Q26770664-573B6516-89B5-49BC-890C-D6F77236512BQ28078076-BB269E08-1EA5-4333-A089-5D4C540CE81BQ30275229-4C9AE8D5-9736-4EA8-A5F8-28F3E97DA75CQ35599741-4A8E9B49-56A8-45A0-A5FD-385D395DA066Q36801911-5C543BC4-6B44-4470-9007-12F917DB5367Q37786616-9BA2C0B8-C212-45B9-96E6-8CA4FEC9AA2EQ38029382-30336872-D9DC-482D-BE9A-33DF0C0B9E95
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Ofatumumab, a human anti-CD20 monoclonal antibody.
@ast
Ofatumumab, a human anti-CD20 monoclonal antibody.
@en
Ofatumumab, a human anti-CD20 monoclonal antibody.
@nl
type
label
Ofatumumab, a human anti-CD20 monoclonal antibody.
@ast
Ofatumumab, a human anti-CD20 monoclonal antibody.
@en
Ofatumumab, a human anti-CD20 monoclonal antibody.
@nl
prefLabel
Ofatumumab, a human anti-CD20 monoclonal antibody.
@ast
Ofatumumab, a human anti-CD20 monoclonal antibody.
@en
Ofatumumab, a human anti-CD20 monoclonal antibody.
@nl
P2860
P1476
Ofatumumab, a human anti-CD20 monoclonal antibody.
@en
P2093
Anders Osterborg
P2860
P304
P356
10.1517/14712590903586239
P407
P577
2010-03-01T00:00:00Z